{"id":"ferric-oxide","rwe":[{"pmid":"41761810","year":"2026","title":"miR-193a-5p carried by ferric oxide nanoparticles interferes with the TGF-β1/Smad signaling pathway and promotes pyroptosis in gastric cancer cells.","finding":"","journal":"Pakistan journal of pharmaceutical sciences","studyType":"Clinical Study"},{"pmid":"41747576","year":"2026","title":"Anisotropic magnetic mesoporous silica catalyst-stir-bars for one-pot reduction-oxidation reaction.","finding":"","journal":"Journal of colloid and interface science","studyType":"Clinical Study"},{"pmid":"41720906","year":"2026","title":"Experimental and theoretical investigation of industrial solar desalination ponds enhanced with nano-ferric oxide for sustainable freshwater production.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"41632848","year":"2026","title":"Molecular tuning of DNA framework-programmed silicification by cationic silica cluster attachment.","finding":"","journal":"Proceedings of the National Academy of Sciences of the United States of America","studyType":"Clinical Study"},{"pmid":"41581618","year":"2026","title":"Biohydrogen evolution via ferric oxide-intercalated graphene oxide modified nickel foam biocathode in single-chamber microbial electrolysis cell.","finding":"","journal":"Bioresource technology","studyType":"Clinical Study"}],"_fda":{"id":"4231d5a3-ee70-83e1-e063-6294a90a0c9b","set_id":"07f4d4d0-9cee-46c3-bc71-2024abd31c9e","openfda":{"upc":["0381370036906"],"unii":["1K09F3G675","88AYB867L5","SOI2LOH54Z"],"route":["TOPICAL"],"rxcui":["1233698"],"spl_id":["4231d5a3-ee70-83e1-e063-6294a90a0c9b"],"brand_name":["Aveeno Anti-Itch Concentrated"],"spl_set_id":["07f4d4d0-9cee-46c3-bc71-2024abd31c9e"],"package_ndc":["69968-0475-4"],"product_ndc":["69968-0475"],"generic_name":["ZINC OXIDE, FERRIC OXIDE RED, AND PRAMOXINE HYDROCHLORIDE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["FERRIC OXIDE RED","PRAMOXINE HYDROCHLORIDE","ZINC OXIDE"],"manufacturer_name":["Kenvue Brands LLC"],"application_number":["M017"],"is_original_packager":[true]},"purpose":["Active ingredients Purpose Calamine 3% Skin Protectant Pramoxine HCl 1% External Analgesic"],"version":"6","stop_use":["Stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days"],"warnings":["Warnings For external use only. Do not use on wounds or damaged skin When using this product do not get into eyes do not bandage tightly Stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away."],"questions":["Questions? call toll-free 866-428-3366 or 215-273-8755 (collect) www.aveeno.com"],"do_not_use":["Do not use on wounds or damaged skin"],"when_using":["When using this product do not get into eyes do not bandage tightly"],"purpose_table":["<table width=\"75%\"><col width=\"75%\" align=\"left\" valign=\"top\"/><col width=\"25%\" align=\"left\" valign=\"top\"/><thead><tr><th><content styleCode=\"italics\">Active ingredients</content></th><th>Purpose</th></tr></thead><tbody><tr><td>Calamine 3%</td><td>Skin Protectant</td></tr><tr><td>Pramoxine HCl 1%</td><td>External Analgesic</td></tr></tbody></table>"],"effective_time":"20251029","active_ingredient":["Active ingredients Purpose Calamine 3% Skin Protectant Pramoxine HCl 1% External Analgesic"],"inactive_ingredient":["Inactive ingredients Water, Glycerin, Distearyldimonium Chloride, Petrolatum, Isopropyl Palmitate, Cetyl Alcohol, Dimethicone, Camphor, Methylparaben, Sodium Chloride, Avena Sativa (Oat) Kernel Oil, Avena Sativa (Oat) Kernal Flour, Avena Sativa (Oat) Kernel Extract"],"storage_and_handling":["Other information Store at Room Temperature"],"indications_and_usage":["Uses For temporary relief of pain and itching associated with: minor burns sunburn minor cuts scrapes insect bites minor skin irritations rashes due to poison ivy, poison oak, or poison sumac Dries the oozing and weeping of poison: ivy oak sumac"],"active_ingredient_table":["<table width=\"75%\"><col width=\"75%\" align=\"left\" valign=\"top\"/><col width=\"25%\" align=\"left\" valign=\"top\"/><thead><tr><th><content styleCode=\"italics\">Active ingredients</content></th><th>Purpose</th></tr></thead><tbody><tr><td>Calamine 3%</td><td>Skin Protectant</td></tr><tr><td>Pramoxine HCl 1%</td><td>External Analgesic</td></tr></tbody></table>"],"spl_unclassified_section":["Drug Facts","Distributed by: JOHNSON & JOHNSON CONSUMER INC. Skillman, NJ 08558"],"dosage_and_administration":["Directions Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: ask a doctor."],"spl_product_data_elements":["Aveeno Anti-Itch Concentrated Zinc Oxide, Ferric Oxide Red, and Pramoxine Hydrochloride WATER GLYCERIN DISTEARYLDIMONIUM CHLORIDE PETROLATUM ISOPROPYL PALMITATE CETYL ALCOHOL DIMETHICONE METHYLPARABEN SODIUM CHLORIDE OAT KERNEL OIL OATMEAL OAT ZINC OXIDE ZINC OXIDE FERRIC OXIDE RED FERRIC OXIDE RED PRAMOXINE HYDROCHLORIDE PRAMOXINE"],"keep_out_of_reach_of_children":["Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 118 mL Bottle Label Dermatologist Recommended Aveeno ® Anti-Itch CONCENTRATED LOTION External Analgesic/Skin Protectant Fast-Acting, Soothing Itch Relief of: Poison Ivy/Oak/Sumac, Insect Bites Soothes Chicken Pox Rash and Allergic Itches Aveeno ® Dermatologist recommended for over 65 years with Triple Oat Complex 4 fl. oz. (118 mL) PRINCIPAL DISPLAY PANEL - 118 mL Bottle Label"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"V08CB03","category":"atc"},{"label":"Topical","category":"route"},{"label":"Aerosol","category":"form"},{"label":"Cream","category":"form"},{"label":"Dressing","category":"form"},{"label":"Active","category":"status"},{"label":"Anemia of prematurity","category":"indication"},{"label":"Arthropod bite wound","category":"indication"},{"label":"Burn injury","category":"indication"},{"label":"Eruption of skin","category":"indication"},{"label":"Hemorrhoids","category":"indication"},{"label":"Iron deficiency anemia","category":"indication"},{"label":"Hematinics","category":"pharmacology"},{"label":"Hematologic Agents","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"RASH","source":"FDA FAERS","actionTaken":"74 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"64 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"55 reports"},{"date":"","signal":"PRURITUS","source":"FDA FAERS","actionTaken":"48 reports"},{"date":"","signal":"CONSTIPATION","source":"FDA FAERS","actionTaken":"45 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"44 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"39 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"34 reports"},{"date":"","signal":"SEIZURE","source":"FDA FAERS","actionTaken":"34 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"33 reports"}],"contraindications":["Chronic Iron Overload","Hemosiderosis","Low blood pressure"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ferric oxide","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:01:26.545347+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:01:31.992953+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ferric oxide","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:01:32.399645+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:01:25.246923+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:01:25.246947+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:01:35.714158+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Phosphate sequestering agent","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:01:33.864975+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4802224/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:01:33.514843+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M017","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:01:25.246950+00:00"}},"allNames":"iron oxide","offLabel":[],"synonyms":["iron oxide","ferric oxide","ferric oxide red","ferric oxide, saccharated","iron oxide, nanoparticles","colloidal ferric oxide"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Iron Oxide","ecosystem":[{"indication":"Anemia of prematurity","otherDrugs":[{"name":"ferrous fumarate","slug":"ferrous-fumarate","company":"Gd Searle Llc"},{"name":"ferrous gluconate","slug":"ferrous-gluconate","company":"Sanofi Aventis Us"},{"name":"ferrous sulfate","slug":"ferrous-sulfate","company":"Lederle"},{"name":"iron","slug":"iron","company":""}],"globalPrevalence":null},{"indication":"Arthropod bite wound","otherDrugs":[{"name":"dexpanthenol","slug":"dexpanthenol","company":"Hospira"},{"name":"pramocaine","slug":"pramocaine","company":"Sebela Ireland Ltd"},{"name":"zinc acetate","slug":"zinc-acetate","company":"Armour Pharm"},{"name":"zinc oxide","slug":"zinc-oxide","company":"Delcor Asset"}],"globalPrevalence":null},{"indication":"Burn injury","otherDrugs":[{"name":"pramocaine","slug":"pramocaine","company":"Sebela Ireland Ltd"},{"name":"zinc acetate","slug":"zinc-acetate","company":"Armour Pharm"},{"name":"zinc oxide","slug":"zinc-oxide","company":"Delcor Asset"}],"globalPrevalence":null},{"indication":"Eruption of skin","otherDrugs":[{"name":"alclometasone dipropionate","slug":"alclometasone-dipropionate","company":""},{"name":"amcinonide","slug":"amcinonide","company":"Astellas"},{"name":"ammonium lactate","slug":"ammonium-lactate","company":"Ranbaxy"},{"name":"benzoyl peroxide","slug":"benzoyl-peroxide","company":"Valeant Intl"}],"globalPrevalence":null},{"indication":"Hemorrhoids","otherDrugs":[{"name":"cortisone acetate","slug":"cortisone-acetate","company":""},{"name":"hydrocortisone","slug":"hydrocortisone","company":"Merck"},{"name":"hydrocortisone acetate","slug":"hydrocortisone-acetate","company":"Merck"},{"name":"lidocaine","slug":"lidocaine","company":"Fresenius Kabi Usa"}],"globalPrevalence":null},{"indication":"Iron deficiency anemia","otherDrugs":[{"name":"cyanocobalamin","slug":"cyanocobalamin","company":""},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"ferric carboxymaltose","slug":"ferric-carboxymaltose","company":"Luitpold"},{"name":"ferric citrate","slug":"ferric-citrate","company":"Keryx Biopharms"}],"globalPrevalence":null},{"indication":"Itching of skin","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"allantoin","slug":"allantoin","company":""},{"name":"ammonium lactate","slug":"ammonium-lactate","company":"Ranbaxy"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Proctitis","otherDrugs":[{"name":"cortisone acetate","slug":"cortisone-acetate","company":""},{"name":"hydrocortisone","slug":"hydrocortisone","company":"Merck"},{"name":"phenylephrine","slug":"phenylephrine","company":"Ani Pharms"},{"name":"pramocaine","slug":"pramocaine","company":"Sebela Ireland Ltd"}],"globalPrevalence":2800000}],"mechanism":{"novelty":"First-in-class","modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Iron Oxide is a small molecule that acts as an iron supplement, increasing the availability of iron for erythropoiesis and hemoglobin synthesis."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4443","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ferric%20oxide","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ferric oxide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:26:44.903160","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:01:37.335222+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ferumoxsil","drugSlug":"ferumoxsil","fdaApproval":"1996-12-06","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"ferric oxide","indications":{"approved":[{"name":"Anemia of prematurity","source":"DrugCentral","snomedId":47100003,"regulator":"FDA","eligibility":"premature infants"},{"name":"Arthropod bite wound","source":"DrugCentral","snomedId":409985002,"regulator":"FDA","eligibility":"patients with arthropod bite wounds"},{"name":"Burn injury","source":"DrugCentral","snomedId":48333001,"regulator":"FDA","eligibility":"patients with burn injuries"},{"name":"Eruption of skin","source":"DrugCentral","snomedId":271807003,"regulator":"FDA","eligibility":"patients with skin eruptions"},{"name":"Hemorrhoids","source":"DrugCentral","snomedId":70153002,"regulator":"FDA","eligibility":"patients with hemorrhoids"},{"name":"Iron deficiency anemia","source":"DrugCentral","snomedId":87522002,"regulator":"FDA","eligibility":"patients with iron deficiency anemia"},{"name":"Itching of skin","source":"DrugCentral","snomedId":418363000,"regulator":"FDA","eligibility":"patients with skin itching"},{"name":"Proctitis","source":"DrugCentral","snomedId":3951002,"regulator":"FDA","eligibility":"patients with proctitis","usPrevalence":null,"globalPrevalence":2800000,"prevalenceMethod":"curated","prevalenceSource":"Orphanet (European Medicines Agency[INST])"},{"name":"Rectal pain","source":"DrugCentral","snomedId":77880009,"regulator":"FDA","eligibility":"patients with rectal pain"},{"name":"Wound","source":"DrugCentral","snomedId":13924000,"regulator":"FDA","eligibility":"patients with wounds"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ferumoxsil","brandName":"ferumoxsil","genericName":"ferumoxsil","approvalYear":"1996","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02511028","phase":"PHASE1","title":"In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2015-11-27","conditions":["Multiple Sclerosis"],"enrollment":14,"completionDate":"2019-01-29"},{"nctId":"NCT07473713","phase":"PHASE1","title":"Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia","status":"NOT_YET_RECRUITING","sponsor":"Tufts Medical Center","startDate":"2026-03","conditions":["Osteopenia"],"enrollment":60,"completionDate":"2028-05"},{"nctId":"NCT07452250","phase":"PHASE2","title":"Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases","status":"RECRUITING","sponsor":"Min Zhou","startDate":"2026-03-08","conditions":["Venous Diseases"],"enrollment":50,"completionDate":"2026-08"},{"nctId":"NCT07461948","phase":"PHASE3","title":"Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2025-10-27","conditions":["Glioblastoma"],"enrollment":15,"completionDate":"2028-10-27"},{"nctId":"NCT03270059","phase":"PHASE2","title":"Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2017-10-06","conditions":["Central Nervous System Neoplasm","Cranial Nerve Disorder","Metastatic Malignant Neoplasm in the Brain"],"enrollment":150,"completionDate":"2028-12-15"},{"nctId":"NCT03953326","phase":"PHASE1,PHASE2","title":"HeartPhone Cancer Survivors Trial 2019","status":"TERMINATED","sponsor":"Penn State University","startDate":"2019-04-23","conditions":["Breast Cancer","Leukemia","Lymphoma"],"enrollment":2,"completionDate":"2020-12-31"},{"nctId":"NCT06104371","phase":"","title":"Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2025-09-01","conditions":["Breast Cancer"],"enrollment":459,"completionDate":"2028-12-31"},{"nctId":"NCT07423000","phase":"PHASE1","title":"A Phase 1 Study of PVT401 in Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Parvus Therapeutics, Inc.","startDate":"2026-04","conditions":["Inflammatory Bowel Disease (IBD)"],"enrollment":36,"completionDate":"2027-11"},{"nctId":"NCT07224464","phase":"NA","title":"The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.","status":"RECRUITING","sponsor":"New Phase Ltd.","startDate":"2025-12-16","conditions":["Metastatic Solid Tumors","Stage 4 Cancer"],"enrollment":9,"completionDate":"2030-12"},{"nctId":"NCT07400406","phase":"","title":"A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-01-26","conditions":["Coronary Artery Calcification"],"enrollment":100,"completionDate":"2027-08-31"},{"nctId":"NCT05340465","phase":"PHASE2","title":"Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants","status":"RECRUITING","sponsor":"University of Washington","startDate":"2022-11-27","conditions":["Prematurity","Iron-deficiency","Iron Deficiency Anemia","Iron Malabsorption"],"enrollment":120,"completionDate":"2027-06-30"},{"nctId":"NCT07313020","phase":"EARLY_PHASE1","title":"Handheld MPI Imaging to Track Stem Cells in Osteoarthritis","status":"ENROLLING_BY_INVITATION","sponsor":"Soochow University","startDate":"2025-12-16","conditions":["Knee Arthritis Osteoarthritis"],"enrollment":10,"completionDate":"2026-12-16"},{"nctId":"NCT04369560","phase":"EARLY_PHASE1","title":"Virtual Histology of the Bladder Wall for Bladder Cancer Staging","status":"RECRUITING","sponsor":"Jodi Maranchie","startDate":"2025-05-23","conditions":["Urinary Bladder Neoplasms"],"enrollment":42,"completionDate":"2028-12-30"},{"nctId":"NCT04900792","phase":"PHASE1","title":"A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bryan Allen","startDate":"2023-02-28","conditions":["Glioblastoma","Glioblastoma Multiforme"],"enrollment":17,"completionDate":"2026-12-31"},{"nctId":"NCT04278651","phase":"PHASE4","title":"Early Antenatal Support for Iron Deficiency Anemia","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2021-09-29","conditions":["Pregnancy Related","Anemia, Iron Deficiency","Anemia of Pregnancy"],"enrollment":80,"completionDate":"2026-12-30"},{"nctId":"NCT06798454","phase":"PHASE1","title":"Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)","status":"COMPLETED","sponsor":"Parvus Therapeutics, Inc.","startDate":"2024-10-15","conditions":["Primary Biliary Cholangitis (PBC)"],"enrollment":24,"completionDate":"2025-04-23"},{"nctId":"NCT07240246","phase":"NA","title":"Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults","status":"RECRUITING","sponsor":"FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation","startDate":"2025-10-24","conditions":["GLP-1","Obesity &Amp; Overweight","Dietary Supplement"],"enrollment":40,"completionDate":"2026-03-11"},{"nctId":"NCT01374919","phase":"NA","title":"Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Auerbach Hematology Oncology Associates P C","startDate":"2011-06","conditions":["Iron Deficiency Anemia"],"enrollment":60,"completionDate":"2012-03"},{"nctId":"NCT04268849","phase":"PHASE3","title":"Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient","status":"RECRUITING","sponsor":"Auerbach Hematology Oncology Associates P C","startDate":"2020-02-27","conditions":["Iron Deficiency Anemia"],"enrollment":104,"completionDate":"2026-02"},{"nctId":"NCT02966665","phase":"PHASE1","title":": Vascular Function in Health and Disease","status":"RECRUITING","sponsor":"Russell Richardson","startDate":"2008-09","conditions":["Chronic Obstructive Pulmonary Disease","Pulmonary Artery Hypertension","Heart Failure","Hypertension"],"enrollment":420,"completionDate":"2026-08"},{"nctId":"NCT03084523","phase":"PHASE1","title":"Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI","status":"COMPLETED","sponsor":"Yale University","startDate":"2017-04-26","conditions":["Stroke","Intracranial Atherosclerosis"],"enrollment":30,"completionDate":"2024-06-03"},{"nctId":"NCT03347617","phase":"PHASE2","title":"Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2017-12-20","conditions":["Glioblastoma"],"enrollment":52,"completionDate":"2025-06-23"},{"nctId":"NCT07147452","phase":"","title":"Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital del SAS de Jerez","startDate":"2017-08-01","conditions":["Gastric Cancer (GC)","Sentinel Lymph Node Biopsy (SLNB)"],"enrollment":44,"completionDate":"2025-08"},{"nctId":"NCT04253626","phase":"PHASE3","title":"Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-01-21","conditions":["Pregnancy Related","Anemia, Iron Deficiency"],"enrollment":83,"completionDate":"2024-07-01"},{"nctId":"NCT02791568","phase":"","title":"Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-01-31","conditions":["Pregnancy","Obesity","Preeclampsia"],"enrollment":121,"completionDate":"2020-07-31"},{"nctId":"NCT04839185","phase":"EARLY_PHASE1","title":"Placental Lesions in Fetal Growth Restrictions","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-04-15","conditions":["Fetal Growth Retardation"],"enrollment":3,"completionDate":"2021-10-06"},{"nctId":"NCT06440408","phase":"PHASE1","title":"Calculating Wall Shear Stress in Infant Pulmonary Veins","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2024-09-30","conditions":["Pulmonary Vein Stenosis"],"enrollment":20,"completionDate":"2027-03"},{"nctId":"NCT06994065","phase":"NA","title":"Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Sindh Institute of Urology and Transplantation","startDate":"2025-06-02","conditions":["Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease"],"enrollment":128,"completionDate":"2025-09"},{"nctId":"NCT06348524","phase":"PHASE3","title":"Ferumoxytol-enhanced Magnetic Resonance Imaging","status":"TERMINATED","sponsor":"Transmed Solutions","startDate":"2015-01-01","conditions":["Coronary Artery Disease"],"enrollment":36,"completionDate":"2022-12-30"},{"nctId":"NCT02070705","phase":"NA","title":"DCE MRI in Patients With Pancreatic Cancer","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2014-01-31","conditions":["Familial Pancreatic Cancer","Pancreatic Adenocarcinoma","Pancreatic Intraductal Papillary-Mucinous Neoplasm"],"enrollment":77,"completionDate":"2024-08-07"},{"nctId":"NCT06482671","phase":"PHASE3","title":"Primary Care dySpEpsia rikkuNshiTo","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2024-10-01","conditions":["Dyspepsia and Other Specified Disorders of Function of Stomach","Postprandial Distress Syndrome"],"enrollment":100,"completionDate":"2026-10-01"},{"nctId":"NCT07066436","phase":"EARLY_PHASE1","title":"ImmunoMRI for Assessment of Tumor-associated Macrophages","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Vienna","startDate":"2025-10","conditions":["DLBCL - Diffuse Large B Cell Lymphoma"],"enrollment":60,"completionDate":"2028-09"},{"nctId":"NCT04363164","phase":"PHASE2","title":"Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2020-08-19","conditions":["Castration Resistant Metastatic Prostate Cancer"],"enrollment":150,"completionDate":"2027-07"},{"nctId":"NCT04261777","phase":"PHASE3","title":"Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients","status":"TERMINATED","sponsor":"Saving Patients' Lives Medical B.V.","startDate":"2020-05-27","conditions":["Prostate Cancer","Metastasis","Prostatectomy"],"enrollment":172,"completionDate":"2025-01-15"},{"nctId":"NCT05811377","phase":"EARLY_PHASE1","title":"Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay","status":"COMPLETED","sponsor":"Christopher J Chermansky, MD","startDate":"2023-03-29","conditions":["IC - Interstitial Cystitis"],"enrollment":8,"completionDate":"2025-05-20"},{"nctId":"NCT00239616","phase":"PHASE2","title":"Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2002-06-05","conditions":["Anemia"],"enrollment":10,"completionDate":"2003-09-15"},{"nctId":"NCT05251493","phase":"PHASE3","title":"Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy","status":"RECRUITING","sponsor":"Saskatchewan Health Authority - Regina Area","startDate":"2022-06-06","conditions":["Iron Deficiency Anaemia in Childbirth"],"enrollment":280,"completionDate":"2027-02-28"},{"nctId":"NCT00236964","phase":"PHASE3","title":"Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2001-02-23","conditions":["Anemia"],"enrollment":96,"completionDate":"2002-05-30"},{"nctId":"NCT06483061","phase":"PHASE2","title":"Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-05-01","conditions":["Epilepsy, Temporal Lobe"],"enrollment":50,"completionDate":"2029-09-01"},{"nctId":"NCT06012760","phase":"NA","title":"The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-04","conditions":["Anemia","Iron Deficiency Anemia","Perioperative","Transfusion","Cardiac Surgery"],"enrollment":400,"completionDate":"2026-03-31"},{"nctId":"NCT06911034","phase":"PHASE4","title":"Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2024-02-01","conditions":["Iron Deficiency Anemia (IDA)","Pregnancy"],"enrollment":60,"completionDate":"2024-09-30"},{"nctId":"NCT06129136","phase":"NA","title":"The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.","status":"COMPLETED","sponsor":"Uute Scientific Oy","startDate":"2023-08-17","conditions":["Atopic Dermatitis"],"enrollment":142,"completionDate":"2024-12-31"},{"nctId":"NCT05359783","phase":"PHASE1,PHASE2","title":"Sentinel Node Localization and Staging with Low Dose Superparamagnetic Iron Oxide","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2021-11-01","conditions":["Breast Cancer","Sentinel Lymph Node"],"enrollment":50,"completionDate":"2024-04-30"},{"nctId":"NCT06674486","phase":"PHASE1","title":"Bioequivalence Study of Iron Sucrose Injection in Healthy Participants","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2024-11-22","conditions":["Bioequivalency","Safety Issues"],"enrollment":48,"completionDate":"2025-03-14"},{"nctId":"NCT03786796","phase":"PHASE2","title":"Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2019-06-03","conditions":["Renal Cell Carcinoma","Metastatic Renal Cell Carcinoma","Kidney Cancer","Renal Carcinoma","Kidney Cancer Metastatic"],"enrollment":20,"completionDate":"2028-03"},{"nctId":"NCT05800600","phase":"PHASE2","title":"Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy","status":"RECRUITING","sponsor":"Fox Chase Cancer Center","startDate":"2023-03-15","conditions":["Anemia"],"enrollment":34,"completionDate":"2027-02-01"},{"nctId":"NCT05557812","phase":"EARLY_PHASE1","title":"A Clinical Trial Comparing FS With ZOE and Non-eugenol Based Materials in Primary Teeth Pulpotomies","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2023-02-02","conditions":["Pulpitis"],"enrollment":19,"completionDate":"2025-02-01"},{"nctId":"NCT02631733","phase":"PHASE1","title":"Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-05-31","conditions":["Malignant Solid Neoplasm"],"enrollment":18,"completionDate":"2023-05-24"},{"nctId":"NCT05353348","phase":"NA","title":"Effect of the Combined Programme on Perioperative Anaemia（CPPA）","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-15","conditions":["Patient Blood Management","Cardiac Surgery","Iron Deficiency Anemia"],"enrollment":110,"completionDate":"2025-04-01"},{"nctId":"NCT01413100","phase":"PHASE2","title":"Scleroderma Treatment With Autologous Transplant (STAT) Study","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2011-09-15","conditions":["Systemic Scleroderma"],"enrollment":21,"completionDate":"2024-09-11"},{"nctId":"NCT01542879","phase":"PHASE1,PHASE2","title":"Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer","status":"RECRUITING","sponsor":"Heike E Daldrup-Link","startDate":"2012-02","conditions":["Cancer"],"enrollment":75,"completionDate":"2026-12"},{"nctId":"NCT05515874","phase":"PHASE4","title":"Predicting Stroke Risk in ICAD With Novel MRI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2021-08-16","conditions":["Intracranial Atherosclerosis"],"enrollment":100,"completionDate":"2026-03-30"},{"nctId":"NCT06693375","phase":"PHASE2","title":"To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.","status":"RECRUITING","sponsor":"NanoEcho AB","startDate":"2024-10-29","conditions":["Healthy Volunteers","Rectal Cancer Patients"],"enrollment":12,"completionDate":"2026-06"},{"nctId":"NCT06690450","phase":"PHASE4","title":"Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2001-08","conditions":["Hemodialysis"],"enrollment":400,"completionDate":"2002-02"},{"nctId":"NCT06622148","phase":"PHASE1","title":"Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2024-06-25","conditions":["Bioequivalency","Safety Issues"],"enrollment":48,"completionDate":"2024-07-26"},{"nctId":"NCT05045872","phase":"PHASE1","title":"Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2021-09-17","conditions":["Chronic Kidney Diseases"],"enrollment":44,"completionDate":"2024-09-03"},{"nctId":"NCT06146751","phase":"","title":"A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-11-06","conditions":["Heart Aneurysm"],"enrollment":320,"completionDate":"2025-03-31"},{"nctId":"NCT03380312","phase":"","title":"MRI Imaging of Ipsilateral Retromuscular Access","status":"COMPLETED","sponsor":"Filip Muysoms","startDate":"2017-09-26","conditions":["Hernia, Incisional"],"enrollment":20,"completionDate":"2022-01-19"},{"nctId":"NCT06596161","phase":"NA","title":"Iron Therpay and Fatigue in Women of Reprodcutive Age","status":"COMPLETED","sponsor":"Central Park Medical College","startDate":"2023-02-25","conditions":["Fatigue Syndrome, Chronic","Fatigue"],"enrollment":194,"completionDate":"2024-03-02"},{"nctId":"NCT06110494","phase":"PHASE4","title":"A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-07-13","conditions":["Apical Periodontitis","Pulp Disease, Dental"],"enrollment":44,"completionDate":"2022-03-10"},{"nctId":"NCT06551805","phase":"","title":"Clinical Research Protocol of Ferumoxytol for Magnetic Resonance Enhancement Imaging in Patients With Atherosclerosis.","status":"RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2024-08-12","conditions":["Atherosclerosis"],"enrollment":100,"completionDate":"2026-12-30"},{"nctId":"NCT03893045","phase":"PHASE3","title":"A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects","status":"RECRUITING","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2019-09-18","conditions":["Iron Deficiency Anemia"],"enrollment":75,"completionDate":"2025-10"},{"nctId":"NCT03619850","phase":"PHASE3","title":"A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)","status":"RECRUITING","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2018-08-13","conditions":["Chronic Kidney Disease; Iron Deficiency Anemia"],"enrollment":129,"completionDate":"2024-08-31"},{"nctId":"NCT06487299","phase":"PHASE2","title":"Iron Administration Via Colonic TET Combined With WMT for ID","status":"NOT_YET_RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2024-07-25","conditions":["Iron Deficiency Anemia in Childbirth"],"enrollment":60,"completionDate":"2026-06-01"},{"nctId":"NCT03679780","phase":"PHASE1","title":"The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction","status":"COMPLETED","sponsor":"The University of Texas at Arlington","startDate":"2018-10-01","conditions":["Cardiovascular Diseases","Cardiovascular Risk Factor","Vasoconstriction"],"enrollment":19,"completionDate":"2023-07-26"},{"nctId":"NCT01995799","phase":"PHASE2","title":"IRon Nanoparticle Enhanced MRI in the Assessment of Myocardial infarctioN","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2013-05-24","conditions":["Myocardial Infarction","Inflammation"],"enrollment":30,"completionDate":"2015-06-30"},{"nctId":"NCT05985551","phase":"","title":"Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Uppsala University","startDate":"2020-01-01","conditions":["Breast Cancer","Chemotherapy Effect","Sentinel Lymph Node"],"enrollment":114,"completionDate":"2027-10-30"},{"nctId":"NCT05166980","phase":"NA","title":"Study of Multiply-fortified Salt Among Women of Reproductive Age and Preschool Children in India","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2022-10-17","conditions":["Nutrient Deficiency"],"enrollment":1389,"completionDate":"2024-05-02"},{"nctId":"NCT06247137","phase":"NA","title":"Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation","status":"COMPLETED","sponsor":"University of Bologna","startDate":"2022-04-01","conditions":["Hypercholesterolemia"],"enrollment":90,"completionDate":"2022-12-30"},{"nctId":"NCT06366698","phase":"PHASE3","title":"Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia","status":"RECRUITING","sponsor":"Arrowhead Regional Medical Center","startDate":"2023-11-21","conditions":["Iron Deficiency Anemia of Pregnancy"],"enrollment":900,"completionDate":"2025-12-30"},{"nctId":"NCT06271421","phase":"NA","title":"NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2024-01-01","conditions":["Glioblastoma Multiforme"],"enrollment":100,"completionDate":"2027-09-01"},{"nctId":"NCT06273501","phase":"NA","title":"MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer","status":"UNKNOWN","sponsor":"Sahlgrenska University Hospital","startDate":"2022-03-24","conditions":["Vulvar Cancer","Lymph Node Metastasis"],"enrollment":20,"completionDate":"2024-12-31"},{"nctId":"NCT06256601","phase":"NA","title":"Clinical Investigation of Effectiveness of a Calcium Silicate Cement","status":"UNKNOWN","sponsor":"Hacettepe University","startDate":"2023-07-12","conditions":["Deep Caries","Dentin Caries"],"enrollment":80,"completionDate":"2024-07"},{"nctId":"NCT06248749","phase":"PHASE3","title":"Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"University of Saskatchewan","startDate":"2024-02-29","conditions":["Anaemia in Ovarian Carcinoma"],"enrollment":200,"completionDate":"2029-12-01"},{"nctId":"NCT04682847","phase":"","title":"Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers","status":"UNKNOWN","sponsor":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","startDate":"2020-11-19","conditions":["Liver Neoplasms","Hepatic Cirrhosis","Hepatic Carcinoma","Liver Cancer","Liver Metastases","Liver Carcinoma","Hepatocellular Carcinoma","Hepatocellular Cancer","Hepatic Atrophy"],"enrollment":40,"completionDate":"2024-12-31"},{"nctId":"NCT00659776","phase":"PHASE2","title":"MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2004-07","conditions":["Nervous System Diseases","Diagnostic Imaging"],"enrollment":255,"completionDate":"2021-12"},{"nctId":"NCT05161507","phase":"","title":"Magseed and Magtrace Localization for Breast Cancer","status":"COMPLETED","sponsor":"University Hospital Ostrava","startDate":"2020-05-04","conditions":["Breast Carcinoma","Breast Carcinoma Metastatic in Lymph Node"],"enrollment":70,"completionDate":"2023-12-31"},{"nctId":"NCT05625698","phase":"NA","title":"Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2021-10-01","conditions":["Breast Cancer"],"enrollment":80,"completionDate":"2023-11-28"},{"nctId":"NCT06169072","phase":"PHASE2","title":"Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2023-01-01","conditions":["Breast Cancer","Sentinel Lymph Node"],"enrollment":220,"completionDate":"2027-07-01"},{"nctId":"NCT01336803","phase":"PHASE2","title":"Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI","status":"COMPLETED","sponsor":"Heike E Daldrup-Link","startDate":"2011-08","conditions":["Bone Cancer","Chondrosarcoma","Ewing's Sarcoma","Osteosarcoma","Rhabdomyosarcoma","Bone Necrosis","Bone Sarcoma","Osteomyelitis"],"enrollment":32,"completionDate":"2023-10"},{"nctId":"NCT04205266","phase":"PHASE4","title":"IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2020-02-14","conditions":["Anemia, Iron Deficiency","Heavy Menstrual Bleeding"],"enrollment":76,"completionDate":"2025-01"},{"nctId":"NCT06061393","phase":"PHASE4","title":"Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia","status":"UNKNOWN","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2023-10-30","conditions":["Anemia, Iron Deficiency","Pregnancy Anemia"],"enrollment":200,"completionDate":"2025-09-20"},{"nctId":"NCT06051565","phase":"PHASE1,PHASE2","title":"Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2021-11-06","conditions":["Diabetes","Magnetic Resonance Imaging"],"enrollment":12,"completionDate":"2022-09-15"},{"nctId":"NCT05357833","phase":"EARLY_PHASE1","title":"Novel Imaging Markers in SPMS","status":"COMPLETED","sponsor":"University of Utah","startDate":"2022-06-01","conditions":["Secondary Progressive Multiple Sclerosis","Multiple Sclerosis, Secondary Progressive","Multiple Sclerosis"],"enrollment":11,"completionDate":"2023-09-01"},{"nctId":"NCT00659126","phase":"PHASE2","title":"Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2006-11-16","conditions":["Metastatic Malignant Neoplasm in the Brain","Primary Brain Neoplasm"],"enrollment":40,"completionDate":"2020-12-31"},{"nctId":"NCT06010537","phase":"EARLY_PHASE1","title":"Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2021-04-28","conditions":["Magnetic Resonance Imaging"],"enrollment":4,"completionDate":"2021-04-30"},{"nctId":"NCT04722692","phase":"PHASE3","title":"Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2020-03-01","conditions":["DCIS","Breast Cancer","Breast Neoplasms","Sentinel Lymph Node"],"enrollment":500,"completionDate":"2027-12-30"},{"nctId":"NCT01052779","phase":"PHASE2","title":"A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2010-03-01","conditions":["Iron Deficiency","Anemia","Kidney Disease"],"enrollment":162,"completionDate":"2012-04-19"},{"nctId":"NCT02694978","phase":"PHASE3","title":"A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2016-02-29","conditions":["Iron Deficiency Anemia"],"enrollment":2014,"completionDate":"2017-07-17"},{"nctId":"NCT04080908","phase":"PHASE4","title":"Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2020-01-15","conditions":["Anemia"],"enrollment":1,"completionDate":"2021-10-19"},{"nctId":"NCT02340962","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2015-05","conditions":["Hepatitis C, Chronic"],"enrollment":25,"completionDate":"2016-10-26"},{"nctId":"NCT05687864","phase":"PHASE1","title":"Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-06-17","conditions":["Magnetic Resonance Imaging","Chronic Kidney Diseases"],"enrollment":30,"completionDate":"2023-12"},{"nctId":"NCT04855266","phase":"PHASE2","title":"Iron Sucrose in Patients With Iron Deficiency and POTS","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2021-04","conditions":["Iron-deficiency","Postural Orthostatic Tachycardia Syndrome"],"enrollment":0,"completionDate":"2023-05"},{"nctId":"NCT05288686","phase":"NA","title":"Use of Superparamagnetic Iron Oxide (SPIO) in Sentinel Lymph Node Detection for Breast Cancer","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2018-07-24","conditions":["Breast Cancer","Sentinel Lymph Node"],"enrollment":282,"completionDate":"2024-06-30"},{"nctId":"NCT03179449","phase":"EARLY_PHASE1","title":"In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI","status":"WITHDRAWN","sponsor":"Michael Iv","startDate":"2017-07-01","conditions":["Childhood Brain Neoplasm"],"enrollment":0,"completionDate":"2025-06-01"},{"nctId":"NCT05792748","phase":"NA","title":"Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth","status":"COMPLETED","sponsor":"King Abdullah University Hospital","startDate":"2013-01-02","conditions":["Pulpotomy"],"enrollment":65,"completionDate":"2014-04-01"},{"nctId":"NCT05576753","phase":"NA","title":"Preperitoneal Umbilical Mesh Area","status":"UNKNOWN","sponsor":"Algemeen Ziekenhuis Maria Middelares","startDate":"2023-02-01","conditions":["Ventral Hernia","Umbilical Hernia","Ventral Incisional Hernia"],"enrollment":20,"completionDate":"2025-04-01"},{"nctId":"NCT05734716","phase":"PHASE4","title":"Colorado-Oregon Altitude Study","status":"COMPLETED","sponsor":"University of Oregon","startDate":"2021-02-17","conditions":["Acute Mountain Sickness"],"enrollment":121,"completionDate":"2023-01-01"},{"nctId":"NCT04542473","phase":"PHASE2,PHASE3","title":"Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2021-07-01","conditions":["SEPSIS","MALNUTRITION, CHILD"],"enrollment":400,"completionDate":"2024-06-30"},{"nctId":"NCT05690542","phase":"","title":"Nanoparticles in Blood: Understanding and Controlling Protein Corona for Optimized Nanomedicine","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-02","conditions":["Coagulation Tests"],"enrollment":60,"completionDate":"2024-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Aerosol, Cream, Dressing","formulations":[{"form":"AEROSOL, SPRAY","route":"TOPICAL","productName":"Calamine Plus"},{"form":"AEROSOL, SPRAY","route":"TOPICAL","productName":"Calamine Plus Pramoxine HCL"},{"form":"AEROSOL, SPRAY","route":"TOPICAL","productName":"Calamine Plus Pramoxine HCl"},{"form":"CREAM","route":"TOPICAL","productName":"Aveeno Calamine and Pramoxine Hydrochloride Anti Itch"},{"form":"CREAM","route":"TOPICAL","productName":"ZINC-OXYDE PLUS"},{"form":"CREAM","route":"TOPICAL","productName":"Au Kah Chuen Fugical"},{"form":"CREAM","route":"TOPICAL","productName":"BABY ANTI MONKEY BUTT DIAPER RASH"},{"form":"CREAM","route":"TOPICAL","productName":"Cellzyme ON-TOX"},{"form":"CREAM","route":"TOPICAL","productName":"Dermagesic"},{"form":"DRESSING","route":"TOPICAL","productName":"Henry Schein Flexible Unna Boot with Calamine"},{"form":"DRESSING","route":"TOPICAL","productName":"McKesson Unna Boot with Calamine 3"},{"form":"DRESSING","route":"TOPICAL","productName":"McKesson Unna Boot with Calamine 4"},{"form":"DRESSING","route":"TOPICAL","productName":"Primer"},{"form":"DRESSING","route":"TOPICAL","productName":"REPARA"},{"form":"DRESSING","route":"TOPICAL","productName":"ReliaMed"}]},"crossReferences":{"NUI":"N0000179132","MMSL":"15814","NDDF":"006622","UNII":"1K09F3G675","VUID":"4020222","CHEBI":"CHEBI:50820","VANDF":"4020161","RXNORM":"1310572","UMLSCUI":"C0060240","chemblId":"CHEMBL4802224","ChEMBL_ID":"CHEMBL2108514","KEGG_DRUG":"D04616","DRUGBANK_ID":"DB11576","PUBCHEM_CID":"91886645","SNOMEDCT_US":"129497004","MESH_DESCRIPTOR_UI":"D000077605","MESH_SUPPLEMENTAL_RECORD_UI":"C000499"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":949,"therapeuticAreas":["Pain"],"atcClassification":{"source":"DrugCentral","atcCode":"V08CB03","allCodes":["V08CB03"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Apr","pmid":"41761810","title":"miR-193a-5p carried by ferric oxide nanoparticles interferes with the TGF-β1/Smad signaling pathway and promotes pyroptosis in gastric cancer cells.","journal":"Pakistan journal of pharmaceutical sciences"},{"date":"2026 Jul","pmid":"41747576","title":"Anisotropic magnetic mesoporous silica catalyst-stir-bars for one-pot reduction-oxidation reaction.","journal":"Journal of colloid and interface science"},{"date":"2026 Feb 21","pmid":"41720906","title":"Experimental and theoretical investigation of industrial solar desalination ponds enhanced with nano-ferric oxide for sustainable freshwater production.","journal":"Scientific reports"},{"date":"2026 Feb 10","pmid":"41632848","title":"Molecular tuning of DNA framework-programmed silicification by cationic silica cluster attachment.","journal":"Proceedings of the National Academy of Sciences of the United States of America"},{"date":"2026 Apr","pmid":"41581618","title":"Biohydrogen evolution via ferric oxide-intercalated graphene oxide modified nickel foam biocathode in single-chamber microbial electrolysis cell.","journal":"Bioresource technology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Iron(III) oxide, also known as ferric oxide, is a naturally occurring inorganic compound with the formula Fe2O3, commonly found in the mineral hematite. It is used as a primary source of iron for the steel industry and is also known as red iron oxide, especially when used in pigments.","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"withdrawn","approval_date":"2009-12-31T00:00:00.000Z","mah":"Guerbet","brand_name_local":"Sinerem","application_number":"EMEA/H/C/000801"},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:01:37.335222+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}